Enfusion Q3 EPS $0.02 Misses $0.05 Estimate, Sales $44.36M Beat $44.05M Estimate
Portfolio Pulse from mahesh@benzinga.com
Enfusion (NYSE:ENFN) reported Q3 earnings of $0.02 per share, missing the analyst consensus estimate of $0.05 by 60%. However, the company's quarterly sales of $44.36 million beat the estimate of $44.05 million by 0.70%, marking a 13.30% increase from the same period last year.
November 07, 2023 | 12:39 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Enfusion's Q3 earnings missed estimates by 60%, but sales exceeded expectations and showed a YoY increase. This mixed report may lead to uncertain market reactions.
Enfusion's earnings miss could negatively impact the stock as it indicates lower profitability. However, the sales beat and YoY growth could offset this as they suggest strong demand and operational efficiency. The net impact is uncertain.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100